NASDAQ · Healthcare · Biotechnology
Oncolytics Biotech Inc.
ONCY
Oncolytics Biotech Inc. CEO Jared Kelly · Market cap $89.6M.
$0.89
-0.01 · -1.16%
52w hi $1.5152w lo $0.33
Off 52w high 31.8%
73
NOTABLE
Current InsiderScore
Corp · 90d
3
3 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
6
1 strong · 5 notable
Analyst consensus
Strong Buy
—
Section 01
Recent Form 4 filings
6 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Feb 12 | Bernd R. Seizinger | Buy | 40,000 | $0.85 | +$34K | 63 | |
| Feb 12 | Wayne Pisano | Buy | 30,000 | $0.84 | +$25K | 63 | |
| Feb 12 | Patricia S Andrews | Buy | 35,400 | $0.86 | +$30K | 73 | |
| Feb 11 | Bernd R. Seizinger | Buy | 60,000 | $0.83 | +$50K | 66 | |
| Feb 11 | Andrew Aromando | Chief Business Officer | Buy | 29,600 | $0.86 | +$25K | 75 |
| Jan 16 | Bernd R. Seizinger | Buy | 100,000 | $1.04 | +$104K | 60 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
JunJulAugSepOctNovDecJanFebMarAprMay